Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
48 Cards in this Set
- Front
- Back
Indication for anti-platelet agents?
|
arterial thrombosis
|
|
Approaches to anti-platelet therapy? (4)
|
1. inhib platelet adhesion
2. inhib platelet activation/secretion 3. inhib platelet aggregation 4. inhib procoagulant activity |
|
Ligand/receptor for platelet adhesion?
|
vW factor/ glycoprotein Ib/IX
|
|
Ligand/receptor for platelet aggregation?
|
Fibrinogen/ GPIIb/IIIa
|
|
Platelet activating substances? (4)
|
1. Thromboxane
2.PAF |
|
Indication for anti-platelet agents?
|
arterial thrombosis
|
|
Approaches to anti-platelet therapy? (4)
|
1. inhib platelet adhesion
2. inhib platelet activation/secretion 3. inhib platelet aggregation 4. inhib procoagulant activity |
|
Ligand/receptor for platelet adhesion?
|
vW factor/ glycoprotein Ib/IX
|
|
Ligand/receptor for platelet aggregation?
|
Fibrinogen/ GPIIb/IIIa
|
|
Platelet activating substances? (4)
|
1. Thromboxane
2.PAF 3. ADP 4. Collagen |
|
What does prostacyclin (PGI2) do for cAMP and aggregation?
|
increase cAMP, decrease aggregation
|
|
What does Thromboxane (TXA2) do for cAMP and aggregation?
|
decrease cAMP, increase aggregation
|
|
Platelet phospholipid surface crucial for?
|
coagulation cascade
|
|
Name the two ADP receptor inhibitors
|
Ticlopidine
Clopidigrel |
|
What do ADP -receptor blockers do?
|
inhibit ADP-induced platelet aggregation
|
|
What is ticlopidine a derivative of?
|
Thienopyridine (prodrug)
|
|
What does ticlopidine do?
|
blocks ADP receptor, inhibiting platelet aggregation and degranulation
|
|
When is ticlopidine used?
|
unstable angina, TIAs, stroke, peripheral vascular disease. After placement of intracoronary stents
|
|
What are ticlopidines side effects? how bad are they?
|
nausea, diarrhea, hemmorhage, neutropenia - BAD
|
|
What is clopidogrel a derivative of?
|
Thienopyridine
|
|
What does clopidogrel do?
|
irreversibly blocks ADP receptors
|
|
How long does it take for clopidogrel to take effect?
|
4 -7 days (lasts 7-10)
|
|
When is clopidogrel used?
|
acute coronary syndrome; risk reduction in pts with recent CVA, MI or PAD
|
|
What did the CAPRIE trial show?
|
clopidogrel slightly better than aspirin in preventing MIs and strokes
|
|
What did the CURE study show?
|
aspirin + clopidogrel better than aspirin alone in preventing MI/stroke/CV death (20% risk reduction)
|
|
What is a dangerous condition associated with both clopidogrel and ticlopidine?
|
TTP - meds block ADAMTS13
|
|
With patient on ticlopidine or clopidogrel, how do you check for TTP?
|
check platelets weekly (1st month of treatment), educate on warning signs of TTP
|
|
What would thrombin receptor inhibitors do?
|
Block platelet activation and aggregation, some under development, none on market
|
|
What does aspirin do? (4 steps)
|
Irreversibly inhibits COX-1 which inhibits arachadonic acid generation which inhibits TXA2 secretion which inhibits platelet activation
|
|
How long until aspirin takes effect? How long does it last?
|
15-20 min, 7 days
|
|
What is the long-term use dose of aspirin?
|
81 mg
|
|
Why use a low dose of aspirin?
|
fewer GI side effects, less risk of bleeding, similar antiplatelet effects
|
|
Who is on lifelong aspirin?
|
Pts with ACS, CVA, or PCI
|
|
What is the anti-platelet mechanism of PDE inhibitors?
|
less PDE means less breakdown of cAMP which means less platelet function
|
|
What are the PDE inhibitors? (3)
|
Dipyridamole, Cilostazol, Aggrenox (aspirin + dipyridamole)
|
|
How do GPIIb/IIIa inhibitors work?
|
bind to activated receptor and directly block platelet aggregation, "final common pathway"
|
|
What are the three GPIIb/IIIa inhibitors?
|
1. Abciximab
2. Eptifibatide 3. Tirofiban |
|
What is abciximab?
|
a chimeric antibody to the GPIIb/IIIa receptor
|
|
How is abciximab given?
|
IV and short term
|
|
At what occupancy does abciximab completely inhibit ADP-induced platelet aggregation?
|
80%
|
|
What is eptifibatide?
|
A cyclic heptapeptide from snake venom that selectively blocks GPIIb/IIIa receptors and prevents platelet aggregation
|
|
When is eptifibatide used?
|
prevention of thrombosis in PCTA (percutaneous angioplasty), MI, angina
|
|
What is the t1/2 of eptifibatide and where is is cleared?
|
2.5 h, the kidney
|
|
What is tirofiban?
|
snake venom GP IIb/IIIa receptor inhibitor.
|
|
When is tirofiban used?
|
PCTA, MI, unstable angina
|
|
What did the PRISM-PLUS study find (wrt tirofiban)?
|
adding tirofiban to heparin decrease risk of repeat MI/death by 35% in 7 days post MI
|
|
How often does thrombocytopenia occur with GPIIb/IIIa inhibitors?
|
0.5% of exposures, more with abciximab, more with repeat exposures
|
|
How is the thrombocytopenia following GPIIb/IIIa inhibitors mediated?
|
Through naturally occuring abs that don't require prior exposure (=weird)
|